跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,616 条关于
“31-GEP”
全部
7,616
临床试验
4,279
药物
761
机构
133
资讯
2,443
去年
31-Gene Expression Profile Test Safely Identifies Melanoma Patients Who Can Avoid Sentinel Lymph Node Biopsy
2年前
Vaxcyte's VAX-31 Demonstrates Positive Phase 1/2 Results, Advancing to Phase 3 for Pneumococcal Disease
去年
Merlin CP-GEP Test Shows Breakthrough Results in Melanoma Risk Assessment and Treatment Planning
去年
ITM-11 Demonstrates Superior Progression-Free Survival Compared to Everolimus in GEP-NETs
11个月前
Sanofi's AlphaMedix Radioligand Therapy Meets All Primary Endpoints in Phase 2 GEP-NET Trial
去年
Everolimus Plus Lanreotide Significantly Extends PFS in GEP-NETs
2个月前
SkylineDx's Merlin CP-GEP Earns FDA Breakthrough Device Designation for Early-Stage Melanoma Risk Assessment
前天
FDA Approves Curium's Bexlutry, First Generic Radioligand, Challenging Lutathera's GEP-NET Monopoly
去年
ITM-11 Radiopharmaceutical Achieves Phase III Success in GEP-NETs, Outperforming Everolimus
去年
Afinitor Plus Somatuline Significantly Prolongs Survival in GEP-NETs
第 1 页,共 245 页
上一页
下一页